Table 5.
Bayesian logistic mixed effects logistic regression results for mortality on extracorporeal membrane oxygenation.
| VV ECMO | VA ECMO | |||||
|---|---|---|---|---|---|---|
| Outcome measure, n (%) | Pulmonary (206) | COVID (408) | p-value | Cardiac (279) | COVID (37) | p-value |
| Mortality | ||||||
| No | 120 (58.3) | 166 (40.7) | <0.001 | 137 (49.1) | 11 (29.7) | 0.041 |
| Yes | 86 (41.7) | 242 (59.3) | 142 (50.9) | 26 (70.3) | ||
| All cause hemorrhage | ||||||
| No | 138 (67.0) | 212 (52.0) | 0.001 | 168 (60.2) | 14 (37.8) | 0.016 |
| Yes | 68 (33.0) | 196 (48.0) | 111 (39.8) | 23 (62.2) | ||
| Hepatic failure | ||||||
| No | 172 (92.0) | 334 (86.8) | 0.09 | 234 (92.9) | 26 (74.3) | 0.002 |
| Yes | 15 (8.0) | 51 (13.2) | 18 (7.1) | 9 (25.7) | ||
| Renal failure | ||||||
| No | 158 (83.6) | 286 (74.3) | 0.016 | 195 (77.4) | 23 (63.9) | 0.119 |
| Yes | 31 (16.4) | 99 (25.7) | 57 (22.6) | 13 (36.1) | ||
| Infection | ||||||
| No | 185 (89.8) | 331 (81.1) | <0.001 | 274 (98.2) | 28 (75.7) | <0.001 |
| Yes new-onset | 5 (2.4) | 54 (13.2) | 1 (0.4) | 5 (13.5) | ||
| Yes pre-existing | 16 (7.8) | 23 (5.6) | 4 (1.4) | 4 (10.8) | ||
DTI, direct thrombin inhibitor; ECMO, extracorporeal membrane oxygenation; VA, venoarterial; VV, venovenous.